Treasure Global (TGL) said Tuesday its Tadaa Technology unit has formed a partnership with Malaysia-based Kainan to provide AI-enabled technology services for a planned $367 million solar farm project.

Nevertheless, shares dropped 27%, with intraday trading volume rising to over 670,000 from a daily average of more than 323,000.

Celldex Therapeutics' (CLDX) two phase 3 trials of barzolvolimab in patients with chronic spontaneous urticaria met their primary and all key secondary endpoints at 12 weeks, the company said Tuesday.

Still, shares dropped 8.7% as intraday trading volume climbed to over 10.3 million from a daily average of more than 986,000.

Price: 2.15, Change: -0.81, Percent Change: -27.36